Stroke Trial, Recruiting NCT05525325 Sponsor: University Hospital Heidelberg Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05525325
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A medical team has decided that the person needs a procedure to remove a blood clot as part of stroke treatment, following their hospital's guidelines.
  • The person is 18 years of age or older, of any sex.
  • The person has a stroke severity score of 4 or higher on a standard medical scale called the NIHSS (a measure of how much the stroke has affected the person).
  • The person is having an acute ischemic stroke (a stroke caused by a blocked blood vessel) affecting the back part of the brain, with a blockage in one or both of the main arteries supplying that area.
  • Consent to take part can be given by the person themselves or their legal representative within 72 hours of treatment — this may happen after treatment has already begun (confirm with trial site).

Who may not be able to join:

  • The person has bleeding inside the brain.
  • The person is in a coma when they arrive at the hospital (a score of 8 or below on the Glasgow Coma Scale, which measures level of consciousness).
  • The person has serious breathing difficulties, has lost the ability to protect their airway, or is vomiting on arrival in a way that means they urgently need to be placed on a breathing machine under general anaesthetic.
  • The person has already been placed on a breathing machine before being randomly assigned to a treatment group in the trial.
  • The person has severe instability in their heart or circulation (for example, due to serious heart failure).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Silvia Schönenberger, MD, University Hospital Heidelberg

Phone: 0049/6221/7504

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Heidelberg
Registry
ClinicalTrials.gov
Start date
1 October 2022
Est. completion
1 January 2029

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Functional outcome as measured by modified Ranking Scale (mRS) after admission.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov